These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9682926)

  • 1. Summary of studies of changes in vascular reactivity caused by natriuretic hormones.
    Purdy RE
    Clin Exp Hypertens; 1998; 20(5-6):705-16. PubMed ID: 9682926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY; Roukoyatkina NI; Pinaev AG; Dmitrieva RI; Fedorova OV
    Eur J Pharmacol; 1995 Feb; 274(1-3):151-8. PubMed ID: 7768267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
    Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
    Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endogenous inhibition of Na-K-ATPase in human hypertension--sodium pump activity as a determinant of peripheral vascular resistance.
    Kramer HJ; Glänzer K; Sorger M
    Clin Exp Hypertens A; 1985; 7(5-6):769-82. PubMed ID: 2990771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digitalislike circulating factor in hypertension: potential messenger between salt balance and intracellular sodium.
    Haddy FJ
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():343-9. PubMed ID: 2176807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
    Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Na+/K+-pump and Na+/Ca2+-exchanger modulates intercellular communication.
    Matchkov VV; Gustafsson H; Rahman A; Briggs Boedtkjer DM; Gorintin S; Hansen AK; Bouzinova EV; Praetorius HA; Aalkjaer C; Nilsson H
    Circ Res; 2007 Apr; 100(7):1026-35. PubMed ID: 17347477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV; Bagrov AY
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Bufo marinus skin toxins on human fetal extracorporeal blood vessels.
    Lim TH; Leitch IM; Boura AL; Read MA; Walters WA
    Toxicon; 1997 Feb; 35(2):293-304. PubMed ID: 9080586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium, Na+-K+ pump inhibitor and low-renin hypertension.
    Haddy FJ
    Clin Invest Med; 1987 Nov; 10(6):547-54. PubMed ID: 2831002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism.
    Taurin S; Dulin NO; Pchejetski D; Grygorczyk R; Tremblay J; Hamet P; Orlov SN
    J Physiol; 2002 Sep; 543(Pt 3):835-47. PubMed ID: 12231642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na(+)-Ca2+ exchange, myoplasmic Ca2+ concentration, and contraction of arterial smooth muscle.
    Rembold CM; Richard H; Chen XL
    Hypertension; 1992 Apr; 19(4):308-13. PubMed ID: 1313392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Na(+), K(+)-ATPase in the hypoxic vasoconstriction in isolated rat basilar artery.
    Shen H; Liang P; Qiu S; Zhang B; Wang Y; Lv P
    Vascul Pharmacol; 2016 Jun; 81():53-60. PubMed ID: 26924456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Na+,K+ pump affects nucleic acid synthesis and smooth muscle cell proliferation via elevation of the [Na+]i/[K+]i ratio: possible implication in vascular remodelling.
    Orlov SN; Taurin S; Tremblay J; Hamet P
    J Hypertens; 2001 Sep; 19(9):1559-65. PubMed ID: 11564975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Na(+)-Ca2+ exchange in the regulation of vascular smooth muscle tension.
    Motley ED; Paul RJ; Matlib MA
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1028-40. PubMed ID: 8386477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
    Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.